Abstract
In 1924, Otto Warburg asked “How does the metabolism of a growing tissue differ from that of a non-growing tissue?” Currently, we know that proliferating healthy and cancer cells reprogramme their metabolism. This typically includes increased glucose uptake, glycolytic flux and lactate synthesis. A key function of this reprogramming is to channel glycolytic intermediates and other metabolites into anabolic reactions such as nucleotide-RNA/DNA synthesis, amino acid-protein synthesis and the synthesis of, for example, acetyl and methyl groups for epigenetic modification. In this review, we discuss evidence that a hypertrophying muscle similarly takes up more glucose and reprogrammes its metabolism to channel energy metabolites into anabolic pathways. We specifically discuss the functions of the cancer-associated enzymes phosphoglycerate dehydrogenase and pyruvate kinase muscle 2 in skeletal muscle. In addition, we ask whether increased glucose uptake by a hypertrophying muscle explains why muscularity is often negatively associated with type 2 diabetes mellitus and obesity.
Original language | English |
---|---|
Pages (from-to) | 2569-2578 |
Number of pages | 10 |
Journal | Sports Medicine |
Volume | 52 |
Issue number | 11 |
Early online date | 23 Apr 2022 |
DOIs | |
Publication status | Published - Nov 2022 |
Bibliographical note
Funding Information:Open Access funding enabled and organized by Projekt DEAL. PB is supported by the EuroTech Postdoc Programme (Grant Agreement Number 754462), co-funded by the European Commission under its framework programme Horizon 2020. Work on this research (HW, PB) is additionally supported by a grant to the Deutsche Diabetes Stiftung.
Publisher Copyright:
© 2022, The Author(s).
Funding
Open Access funding enabled and organized by Projekt DEAL. PB is supported by the EuroTech Postdoc Programme (Grant Agreement Number 754462), co-funded by the European Commission under its framework programme Horizon 2020. Work on this research (HW, PB) is additionally supported by a grant to the Deutsche Diabetes Stiftung.
Funders | Funder number |
---|---|
Deutsche Diabetes Stiftung | |
EuroTech Postdoc Programme | |
Horizon 2020 Framework Programme | 754462 |
European Commission |